AHA 2023 — In this short interview, we are joined by Dr John Hummel (Ohio State University, US) to discuss the findings from the JEWEL-IDE (NCT05201495) study, which investigated the use of the Jewel patch-wearable cardioverter defibrillator (PWCD) system in participants who were at high risk for sudden cardiac arrest. This was a multicenter, prospective, single-arm trial, with 290 participants. 

Findings suggest that Jewel is safe and effective, with a high number of patient saves, no deaths or serious adverse events. There was a high patient compliance and low false alarm rate, and the device was well-tolerated for extended prescription durations.

 Questions

1. What are the unmet needs for patients at high risk for cardiac arrest?
2. What was the study design and the patient population?
3. Could you tell us a bit more about the JEWEL system?
4. What were the key findings?
5. What are your take-home messages?
6. What further study is needed?

Recorded on-site at AHA Scientific Sessions 2023, Philadelphia.

For more content from #AHA23 head to the Late-Breaking or the CardioNerds Conference Scholars Collection.

This is an independent interview conducted by Radcliffe Cardiology.

Interviewer: Mirjam Boros
Editor: Jordan Rance
Video Specialists: Dan Brent